← Evidence map

ReviewFEBS open bio2026

Digital twins to accelerate target identification and drug development for immune-mediated disorders.

Anna Niarakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41872995